Praxis Precision Medicines (PRAX)
(Delayed Data from NSDQ)
$50.80 USD
-2.12 (-4.01%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $50.64 -0.16 (-0.31%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum D VGM
Brokerage Reports
Praxis Precision Medicines, Inc. [PRAX]
Reports for Purchase
Showing records 41 - 60 ( 107 total )
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Takeaways from Company Presentations at Tremor Congress 2023
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Upcoming Readouts Bring Epilepsy Portfolio to Center Stage; Adjusting PT to $15; Reit. Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Takeaways From Our Conversation With Praxis Precision Medicines Management; Reit. Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Praxis'' Essential Tremor Program, Bent But Not Broken
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Sticking With The Sidelines, As PRAX-944 To Advance To Phase 3
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Praxis Unveils New Therapy Development Platforms Highlighting That There''s More Here Than Essential1; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Essentially Waiting - Essential1 Data On Track For 1Q23 As 4Q22 Results Post
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
HCW 2023 Top Picks: Seize the Opportunities
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Essential1 Readout Should Give Praxis Its Mojo Back; Raise PT to $16; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Essentially A Big Catalyst For PRAX - Ahead Of The PRAX-944/Essential1 Readout
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology - Feeling Busier than Usual? Revisiting Biotech Catalyst Activity
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
UCB Taps Praxis for Epilepsy Research Collaboration; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
A Little More Patience Needed, But Plenty to Look Forward; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D